Clinical Trial Update: A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two HIV/HCV treatments in patients co-infected with HIV and hepatitis C, evaluating effectiveness, safety, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Hepatitis C

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hepatitis C | Phase 2 | Status: COMPLETED